Radiopharmaceutical development of a freeze-dried kit formulation for the preparation of [99mTc-EDDA-HYNIC-D-Phe1, Tyr3]-octreotide, a somatostatin analog for tumor diagnosis

This publication has 20 references indexed in Scilit:

• 99mTc-EDDA/HYNIC-TOC and 18F-FDG in thyroid cancer patients with negative 131I whole-body scans
  European Journal of Nuclear Medicine and Molecular Imaging, 2003
• Peptide Targeted Imaging of Cancer
  Cancer Biotherapy & Radiopharmaceuticals, 2003
• Preparation via coligand exchange and characterization of [^99mTc‐EDDA‐HYNIC‐D‐Phe¹,Tyr³]Octreotide (^99mTc–EDDA/HYNIC–TOC)
  Journal of Labelled Compounds and Radiopharmaceuticals, 2003
• Somatostatin receptor imaging of non-small cell lung cancer with 99mTc depreotide
  Seminars in Nuclear Medicine, 2002
• [99mTc]Demotate, a new 99mTc-based [Tyr3]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results
  European Journal of Nuclear Medicine and Molecular Imaging, 2002
• Towards Developing A Non‐SnCl2 Formulation for RP444, A New Radiopharmaceutical for Thrombus Imaging
  Journal of Pharmaceutical Sciences, 2001
• The integrity of the disulfide bond in a cyclic somatostatin analog during 99mtc complexation reactions
  Nuclear Medicine and Biology, 1999
• Preparation, ^99mTc-Labeling, and in Vitro Characterization of HYNIC and N₃S Modified RC-160 and [Tyr³]Octreotide
  Bioconjugate Chemistry, 1999
• Somatostatinrezeptor- szintigraphie Methodik, Indikationen, Ergebnisse
  Der Radiologe, 1996
• [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation
  Life Sciences, 1991